Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Concord Medical Services Holdings Ltd (CCM) Cash Flow Statement

Concord Medical Services Holdings Ltd (CCM) generated -$201.8M of operating cash flow over the twelve months to its latest filing, spent $91.3M on capital expenditure and had free cash flow of -$293.1M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · read by EquiReason

CCMConcord Medical Services Holdings LtdFollow CCM — free
Medical Care Facilities · Healthcare
—
Price chart with a free account
Market cap
17.6M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
—
LineFY2011
Dec 11
FY2012
Dec 12
FY2013
Dec 13
FY2014
Dec 14
FY2015
Dec 15
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Trend
Operating cash flow137.1259.5259.0490.4-175.1-78.126.7-38.6-195.3-229.8-359.3-216.7-276.5-397.7-201.8-201.8
Capital expenditure18.365.974.651.547.878.991.3165.6232.7168.0760.6383.8115.7400.791.3-91.3
Free cash flow118.8193.6184.5438.9-222.9-157.0-64.5-204.2-428.0-397.8-1,119.9-600.5-392.2-798.4-293.1-293.1
Dividends paid55.2——453.60.0285.80.00.0————————
Share repurchases6.943.56.0—19.730.40.00.0————————
Stock-based compensation9.29.18.87.38.18.411.611.120.620.614.7-5.90.0———

USD millions · SEC XBRL

Concord Medical Services Holdings Ltd — questions

What is Concord Medical Services Holdings Ltd's operating cash flow?
-$201.8M over the twelve months to the latest filing.
How much does Concord Medical Services Holdings Ltd spend on capital expenditure?
$91.3M over the twelve months to the latest filing.
What is Concord Medical Services Holdings Ltd's free cash flow?
-$293.1M over the twelve months to the latest filing: operating cash flow minus capital expenditure.

Every figure on this page comes from Concord Medical Services Holdings Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.